MetaCap

Stablecoin Development (SDEV) vs Talphera (TLPH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Talphera (TLPH) has outperformed Stablecoin Development (SDEV) over the past year, losing 41.4% versus a loss of 88.4%. Over five years, TLPH leads with a -94.0% price change compared with -100.0% for SDEV. Talphera is the larger company by market cap ($40.8 million vs $36.9 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SDEV-88.37%TLPH-41.40%
+2239%+1020%-199%
Nov 21, 20251 yearNov 20, 2026
SDEV-99.98%TLPH-94.55%
+20%-43%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SDEV versus TLPH key metrics
MetricSDEVTLPH
Share price$0.50$0.7852
Market cap$36.90M$40.80M
1-day change-10.30%+6.25%
YTD return-98.23%-31.12%
1-year return-88.37%-41.40%
5-year return-99.98%-93.96%
P/E ratio (TTM)0.19—
EPS (TTM)$2.70$-0.21
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$28.00K
Net income (latest FY)$-630.78M$-14.29M
Operating margin—-48157.14%
Net margin—-51035.71%
52-week high$99.75$1.57
52-week low$0.467$0.69
Distance from 52-week high-99.50%-49.99%
Analyst consensus—none
Avg. price target upside—+298.62%
Average volume16.98M144.13K
Shares outstanding73.80M51.96M
Employees212
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TLPH has outperformed SDEV by 47.0 percentage points over the past year.

About Stablecoin Development

SDEV stock →

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

About Talphera

TLPH stock →

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit.

Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees

SDEV vs TLPH FAQ

Which is bigger, Stablecoin Development or Talphera?

Talphera (TLPH) is larger, with a market capitalization of $40.80M compared with $36.90M for Stablecoin Development (SDEV).

Which stock has performed better over the past year, SDEV or TLPH?

TLPH returned -41.40% over the past 12 months, compared with -88.37% for SDEV (price return, excluding dividends). Past performance does not predict future results.

Are Stablecoin Development and Talphera in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons